Table 1.
Clinical and demographic characteristics of the subjects with and without CF.
|
Overall (N = 130) |
CF+ (N = 30) |
CF- (N = 100) |
P-value | |
|---|---|---|---|---|
| Men, % | 80 (61.54%) | 13 (56.67%) | 67 (67.00%) | 0.151 |
| Age, years | 66.78 (9.16) | 69.87 (9.08) | 63.25 (8.66) | 0.000 |
| Education, years Comorbidity number BMI, kg/m2 |
10.05 (3.61) 1.57 (0.99) 25.17 (3.26) |
8.60 (3.64) 1.83 (1.12) 23.21 (3.70) |
10.48 (3.50) 1.49 (0.94) 25.77 (2.89) |
0.012 0.095 0.000 |
| MMSE, score | 27.60 (1.57) | 25.90 (1.09) | 28.11 (1.32) | 0.000 |
| VFT, words | 17.10 (3.88) | 13.98 (3.16) | 18.04 (3.58) | 0.000 |
| CDT, score | 11.67 (1.37) | 10.67 (1.32) | 11.97 (1.24) | 0.000 |
| TMT-B, seconds | 77.88 (21.42) | 95.96 (18.20) | 72.46 (19.29) | 0.0000 |
| Fazekas score DTC |
1.72 (0.72) 14.39 (9.43) |
2.23 (0.68) 19.73 (10.60) |
1.56 (0.66) 12.78 (8.46) |
0.000#
0.000 |
Mean (Standard Deviation).
#
P < 0.05 CF+ relative to CF- CF+, with cognitive frailty; CF-, without cognitive frailty; BMI, Body Mass Index; MMSE, Mini-Mental State Evaluation; VFT, Verbal Fluency Test; CDT, Clock Drawing Test; TMT-B, Trail Making Test-B; DTC, Dual Task Cost.